AMIX — Autonomix Medical, Inc.

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1617867 ·
Last close
$3.11
Market Cap
$3.02M
52W High
$32.55
52W Low
$2.44
ADV30
200,302
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 0 — -2,770,000 -2,728,000 3,980,000 3,460,000 818,000
Mar 2026 0 — -2,737,000 -2,666,000 7,600,000 7,004,000 1,705,000
Dec 2025 0 — -3,343,000 -3,261,000 10,211,000 9,934,000 1,650,000
Sep 2025 0 — -7,534,000 -7,451,000 7,932,000 7,477,000 1,487,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-12,282,000
Investing CF
$-10,000
Financing CF
$10,160,000
CapEx
$-12,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-89.67
As of
2026-08-16

Balance + Analyst (yfinance extras)

Retained Earnings
$-67,094,000
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-16,715,000
Pretax Income TTM
$-16,715,000
Interest Exp TTM
$0
Analysts
2

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Mar 2026 0 -17,034,000 -16,715,000 7,600,000 1,705,000 5,895,000 -12,282,000
Mar 2025 0 -11,588,000 -11,410,000 9,806,000 1,707,000 8,099,000 -8,258,000
Mar 2024 0 -7,474,000 -15,426,000 9,407,000 1,779,000 7,628,000 -6,648,000
Mar 2023 0 -1,990,000 -1,990,000 865,000 221,000 644,000 -1,854,000

TTM Snapshot

Revenues TTM
$319,000
NetIncome TTM
$-16,715,000
OpCashFlow TTM
—
Assets (Latest)
$10,211,000
Forward EPS
$-7.40

Peers — same industry

TickerNameMarket CapLastDaily %
NXL Nexalin Technology, Inc. $3.01M $3.63 —
VVOS Vivos Therapeutics, Inc. $3.00M $0.15 —
ADGM Adagio Medical Holdings, Inc. $2.89M $0.13 —
ADMT ADM TRONICS UNLIMITED, INC. $3.38M $0.05 —
DROR Dror Ortho-Design, Inc. $3.42M $0.00 —

News headlines (Yahoo Finance, 1h cache)

Autonomix Medical Strengthens Patent Protection for Platform Technology Enabling Precision Access, Treatment Delivery and Procedural Validation
2026-10-02 12:05 · Yahoo
Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance
2026-09-30 12:30 · Yahoo
Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation Platform
2026-09-24 12:30 · Yahoo
Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors
2026-09-16 12:30 · Yahoo
Autonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026
2026-09-01 12:30 · Yahoo
Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery
2026-08-26 12:30 · Yahoo
Autonomix Medical Enters into $4.9 Million Warrant Inducement Priced at a Premium to Market Under Nasdaq Rules
2026-08-25 01:06 · Yahoo
Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission
2026-08-12 12:15 · Yahoo
Autonomix Medical Receives U.S. Patent for Precision Neuromodulation Platform Expansion
2026-08-04 15:24 · Yahoo
Autonomix Medical Expands Precision Neuromodulation Platform with Broad New U.S. Patent Supporting Nerve Sensing, Mapping and Targeted Therapy
2026-08-04 12:15 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.